Characteristics | Relapsing Patients, n = 171 | Nonrelapsing Patients, n = 155 | p |
---|---|---|---|
Demographics | |||
Female | 128 (75) | 111 (72) | 0.51 |
Age, yrs | 74 (53–89) | 76 (48–92) | 0.09 |
Cardiovascular risk factors | |||
Tobacco use | 31 (18) | 26 (17) | 0.75 |
Hypertension | 87 (51) | 84 (54) | 0.55 |
Dyslipidemia | 50 (29) | 53 (34) | 0.34 |
Diabetes mellitus | 15 (9) | 19 (12) | 0.30 |
History of coronary disease | 14 (8) | 10 (6) | 0.55 |
History of stroke | 7 (4) | 18 (12) | 0.01 |
Clinical manifestations | |||
BMI | 25 (16–37) | 25 (16–36) | 0.20 |
Fever | 38 (22) | 28 (18) | 0.35 |
Cranial manifestations | 152 (89) | 145 (94) | 0.14 |
Headaches | 136 (80) | 134 (86) | 0.1 |
Scalp tenderness | 75 (44) | 66 (43) | 0.82 |
Jaw claudication | 69 (40) | 64 (41) | 0.87 |
Ophthalmic trouble | 38 (22) | 41 (26) | 0.37 |
Temporal pulse absence | 38 (22) | 40 (26) | 0.45 |
Limb claudication | 9 (5) | 6 (4) | 0.55 |
Polymyalgia rheumatica | 92 (54) | 73 (47) | 0.23 |
Laboratory tests | |||
ESR, mm | 68 (7–138) | 66 (7–138) | 0.71 |
CRP, mg/l | 78 (3–398) | 70 (3–424) | 0.40 |
Hemoglobin, g/dl | 11.2 (7.4–14.7) | 11.5 (8.5–15.3) | 0.15 |
Platelets, g/mm3 | 404 (140–772) | 439 (196–785) | 0.46 |
Positive histology | 105 (64) | 101 (66) | 0.71 |
Positive TAB | 104 (63) | 99 (66) | 0.59 |
Large-vessel involvement on imaging | 45/114 (39) | 22/94 (23) | 0.01 |
Treatment | |||
GC doses, mg/kg | |||
At onset | 0.73 (0.25–1.45) | 0.77 (0.29–1.45) | 0.09 |
At Month 3 | 0.35 (0.12–1.04) | 0.34 (0.14–0.83) | 0.98 |
At Month 6 | 0.19 (0.08–0.7) | 0.175 (0.06–0.65) | 0.15 |
At Month 12 | 0.12 (0.02–0.53) | 0.09 (0.01–0.56) | < 0.0001 |
Discontinuation of GC | 95 (56) | 110 (71) | 0.004 |
Duration of GC treatment, mos | 29 (10–212) | 18 (6–156) | < 0.0001 |
Cardiovascular complications | 29 (18) | 31 (20) | 0.48 |
Death | 25 (15) | 24 (15) | 0.83 |
Values are n (%) or median (range) unless otherwise specified. GCA: giant cell arteritis; CRP: C-reactive protein; BMI: body mass index; ESR: erythrocyte sedimentation rate; TAB: temporal artery biopsy; GC: glucocorticoids.